The dependence of efficiency of transmembrane molecular transfer using electroporation on medium viscosity
- 11 March 2015
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 17 (3-5) , 80-86
Abstract
Background: In the present study, we aimed to evaluate the efficiency of drug and gene electrotransfer into cells in vitro depending on medium viscosity.Methods: Experiments were performed using Chinese hamster ovary cells. Efficiency of molecular electrotransfer depending of medium viscosity was evaluated using two different electroporation conditions: a high‐voltage (HV) pulse and a combination of a high‐voltage pulse and a low‐voltage pulse (HV + LV). To evaluate the efficiency of molecular electrotransfer, anticancer drug bleomycin and two different plasmids coding for green fluorescent protein and luciferase were used.Results: We found that a slight increase in medium viscosity from 1.3–1.4 mPa·s significantly decreased the transfection efficiency, both in terms of transfected cells and total protein production, which was abolished completely with an increase in medium viscosity to 6.1 mPa·s. Notably, at this medium viscosity, electrotransfer of the small anticancer drug was still efficient. Using HV and HV + LV pulse combinations, we showed that a decrease of DNA electrotransfer, especially at lower medium viscosities, can be compensated for by the LV pulse to some extent. On the other hand, the addition of the LV pulse after the HV pulse did not have any positive effect on the efficiency of bleomycin electrotransfer.Conclusions: These findings demonstrate that transfection is very susceptible to medium viscosity and highlights the importance of the electrophoretic component in experiments when a considerable transfection level is needed. Copyright © 2015 John Wiley & Sons, Ltd.Keywords
Funding Information
- Lietuvos Mokslo Taryba (SVE-08/2014)
This publication has 34 references indexed in Scilit:
- Gene Electrotransfer in Clinical Trials2014
- Gene Electrotransfer of Plasmid Antiangiogenic Metargidin Peptide (AMEP) in Disseminated Melanoma: Safety and Efficacy Results of a Phase I First-in-Man StudyHuman Gene Therapy Clinical Development, 2013
- Electric Field-Driven Water Dipoles: Nanoscale Architecture of ElectroporationPLOS ONE, 2013
- Molecular-Level Characterization of Lipid Membrane Electroporation using Linearly Rising CurrentThe Journal of Membrane Biology, 2012
- Transport of siRNA through Lipid Membranes Driven by Nanosecond Electric Pulses: An Experimental and Computational StudyJournal of the American Chemical Society, 2012
- Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic MelanomaJournal of Clinical Oncology, 2008
- Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodesEuropean Journal of Cancer Supplements, 2006
- Membrane Electroporation: A Molecular Dynamics SimulationBiophysical Journal, 2005
- Electric Pulse‐Mediated Gene Delivery to Various Animal Tissues2005
- Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trialCancer, 1993